- Home
- CYTK vs BE Comparison
CYTK vs BE Comparison
Compare CYTK & BE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CYTK
- BE
- Stock Information
- Founded
- CYTK 1997
- BE 2001
- Country
- CYTK United States
- BE United States
- Employees
- CYTK N/A
- BE N/A
- Industry
- CYTK Biotechnology: Pharmaceutical Preparations
- BE Industrial Machinery/Components
- Sector
- CYTK Health Care
- BE Energy
- Exchange
- CYTK Nasdaq
- BE Nasdaq
- Market Cap
- CYTK 5.6B
- BE 5.5B
- IPO Year
- CYTK 2004
- BE 2018
- Fundamental
- Price
- CYTK $44.53
- BE $23.45
- Analyst Decision
- CYTK Strong Buy
- BE Buy
- Analyst Count
- CYTK 17
- BE 18
- Target Price
- CYTK $82.00
- BE $24.67
- AVG Volume (30 Days)
- CYTK 1.6M
- BE 6.9M
- Earning Date
- CYTK 05-07-2025
- BE 05-08-2025
- Dividend Yield
- CYTK N/A
- BE N/A
- EPS Growth
- CYTK N/A
- BE N/A
- EPS
- CYTK N/A
- BE N/A
- Revenue
- CYTK $18,474,000.00
- BE $1,473,856,000.00
- Revenue This Year
- CYTK $176.28
- BE $20.03
- Revenue Next Year
- CYTK $361.83
- BE $20.86
- P/E Ratio
- CYTK N/A
- BE N/A
- Revenue Growth
- CYTK 145.34
- BE 10.53
- 52 Week Low
- CYTK $40.53
- BE $9.02
- 52 Week High
- CYTK $75.71
- BE $29.83
- Technical
- Relative Strength Index (RSI)
- CYTK 50.85
- BE 46.65
- Support Level
- CYTK $42.66
- BE $22.39
- Resistance Level
- CYTK $48.43
- BE $26.53
- Average True Range (ATR)
- CYTK 2.09
- BE 1.62
- MACD
- CYTK 0.28
- BE -0.05
- Stochastic Oscillator
- CYTK 51.02
- BE 32.29
About CYTK Cytokinetics Incorporated
Cytokinetics Inc is a biotechnology company that develops muscle biology-driven treatments for diseases characterized by reduced muscle function, muscle weakness, and fatigue. The company develops treatments for diseases such as amyotrophic lateral sclerosis, heart failure, spinal muscular atrophy, and chronic obstructive pulmonary diseases. The treatment is based on small molecules specifically engineered to increase muscle function and contractility. The company is developing muscle-directed investigational medicines that may potentially improve the health span of people with devastating cardiovascular and neuromuscular diseases of impaired muscle function.
About BE Bloom Energy Corporation
Bloom Energy designs, manufactures, sells, and installs solid-oxide fuel cell systems ("Energy Servers") for on-site power generation. Bloom Energy Servers are fuel-flexible and can use natural gas, biogas, and hydrogen to create 24/7 electricity for stationary applications. In 2021, the company announced plans to leverage its technology and enter the electrolyzer market. Bloom primarily sells its systems in the United States and internationally.